| Variable | Category | Frequency (n = 60) | Percentage (%) | |
| Median age[IQR] | 44.0 [36 - 55] |
| ||
| Age groups (years) | [18 - 30] | 4 | 6.7 | |
| [30 - 40] | 16 | 27.7 | ||
| [40 - 50] | 20 | 33.3 | ||
| [50 - 60[ | 7 | 11.7 | ||
| ≥60 | 13 | 21.7 | ||
| Sex | Male | 41 | 68.3 | |
| Female | 19 | 31.7 | ||
| Comorbidities | Hepatitis D | 20 | 33.3 | |
| Hypertension | 12 | 20 | ||
| Diabetes mellitus | 7 | 11.7 | ||
| Liver cirrhosis | 5 | 8.3 | ||
| HIV | 3 | 5 | ||
| Hepatocellular carcinoma | 1 | 1.7 | ||
| Medication | Herbal medication | 13 | 21.7 | |
| ACEI | 8 | 13.3 | ||
| Metformin | 7 | 11.7 | ||
| Diuretics | 5 | 8.3 | ||
| ARB | 5 | 8.3 | ||
| NSAIDS | 4 | 6.7 | ||
| Median baseline creatinine [IQR] | 0.95 mg/dL [0.80 - 1.10] | |||
| Baseline creatinine | Raised | 1 | 1.7 | |
| Normal | 59 | 98.3 | ||
| Mean baseline eGFR ± SD | 93.18 ± 20.10 mL/min/1.73m2 | |||
| Baseline eGFR | Decreased | 1 | 1.7 | |
| Normal | 59 | 98.3 | ||
| Median ALAT [IQR] | 37.00 IU/L [22.00 - 83.25] | |||
| Baseline ALAT | Raised | 30 | 50 | |
| Normal | 30 | 50 | ||
| Median ASAT [IQR] | 34.00 IU/L [25.50 - 68.75] | |||
| Baseline ASAT | Raised | 29 | 48.3 | |
| Normal | 31 | 51.7 | ||
| Median baseline viral load [IQR] | 1362.00 IU/mL [125.00 - 21642.00] | |||